Levomethadone hydrochloride

Levomethadone hydrochloride is a synthetic, long-acting opioid agonist utilized mainly in Europe for opioid substitution therapy to manage opioid dependence and treat severe chronic pain. It is the stereochemically pure (R)-(−)-enantiomer of methadone. Standard methadone prescribed in many regions (like the US) is a racemic mixture containing equal parts levomethadone and dextromethadone. However, levomethadone carries virtually all of the therapeutic opioid activity, making it twice as potent as racemic methadone. It is grouped under the following drug class(es): Opioid dependence agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include l-Methadone hydrochloride, l-Polamidon hydrochloride, (-)-Methadone hydrochloride and l-Amidone hydrochloride. It is listed as a controlled drug substance (Schedule II). Its PubChem CID is 22266.

CAS No 5967-73-7
Molecular Formula C21H28ClNO
Molecular Weight 345.9 g/mol
Synonyms (6R)-6-(dimethylamino)-4,4-diphenylheptan-3-one;hydrochloride

Frequently Asked Questions